IACC 2017 Summary of Advances in Autism Spectrum Disorder Research
The Interagency Autism Coordinating Committee’s (IACC) April 2018 publication, 2017 Summary of Advances (PDF), provides short, plain language summaries of the top 20 research articles selected by the IACC. The studies selected for 2017 have provided new insight into potential biomarkers to predict risk of autism spectrum disorder (ASD), developmental trajectories of children with ASD, and the impact of the various prenatal exposures on ASD risk. The advances also include studies that investigated treatments and interventions for both ASD and co-occurring conditions, the impact of policy changes on ASD health care spending, patterns of injury mortality, and prevalence differences across demographic groups.
The Interagency Autism Coordinating Committee (IACC) is a federal advisory committee that coordinates federal efforts and provides advice to the Secretary of Health and Human Services on issues related to autism spectrum disorder (ASD). Through its inclusion of both federal and public members, the IACC helps to ensure that a wide range of ideas and perspectives are represented and discussed in a public forum. The Autism CARES Act reauthorized the committee to continue its work until September 30, 2019.